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COVID-19 PANDEMIC DISEASE: A Bibliometric Study 
 
 
Dr. Jayaprakash G Hugar* 
Dr. M. M. Bachalapur** 
& 
Dr. Prasanna Kumara B.M*** 
 
Abstract: 
Novel Coronavirus pandemic disease is spreading very fast worldwide. More than 200 
countries are affected due to the deadly virus. An attempt has been made to study the 
bibliometric study on COVID-19 and analysed the data and presented tabular and graphical 
form. Published bibliographic data were collected from 2001 to 2020 from Scopus citation 
databases. This present study evaluated the contemporary scientific literature to assess the 
literature available on COVID-19, and identify the leading research patrons and explore the 
same. This study provided a global bibliometric evaluation of COVID-19 studies, which may 
facilitate ongoing and future research. 
 
Background: Novel coronavirus disease (COVID-19) was initially detected in China a short 
time ago, and ultimately developed a most important global health nervousness due to its nature 
and extensive spreading everywhere in this world. Despite a rising awareness in COVID-19 
among the people, little is understood about the present state of data on COVID-19, which 
may describe what proportion is understood about this difficulty. This bibliometric analysis 
assessed the present-day scientific information to measure the growth of literature available on 
COVID-19, recognise the leading research stakeholders, and explore the same.   
 
Methods: Bibliometric records on Coronavirus Disease – 19 reported studies published till 
April 1, 2020, were recovered from the leading database such as SCOPUS. Further, collected 
suitable data were analysed with the help of MS-Excel. 
 
Results: A total of 541 publications and 11251citations were taken for this study, comprising 
of journal articles, reviews, letters, and other publications. The average number of authors and 
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citations per document was 2.45 and 70.76 correspondingly. Also, the best ten articles, authors, 
and journals were recognised built on the occurrence of publications. It is identified that, 
Medicine, Immunology and Microbiology and other pandemic related topics are associated 
with COVID - 19 are the major area of study during the study period. Highest publications 
have appeared in PLOS One journal. Highest publications emerged from USA.   
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1. Introduction and Need for the Study 
The present COVID-19 epidemic is unique, but the worldwide reaction draws on the 
experience learned from other viruses out breaks over the preceding several eras (WHO). The 
coronavirus which was known as SARS-CoV-2 and caused a serious respiratory disease, 
named as COVID-19 infection1, 2, had been infected by more than 3,309,107 people, 2, 34,143 
dead, every day around 5000 cases are detected and being spread in 212 countries and territories 
around the world by May 01, 20203. From January to May 1, 2020 totally 44, 24,135 people 
died due to communicable diseases deaths in this world. The continuing outbreak of COVID-
19 had raised serious concerns of more and more researchers. At least 55 papers written in the 
English language on COVID-19 had been published in the journals in the year 2020 till April 
30.  
Coronaviruses are RNA viruses widely found among many mammal species, including 
human beings.4 Although these viruses generally have low virulance, two epidemics by acute 
respiratory pattern coronavirus (SARS-CoV) and Middle East respiratory syndrome 
coronavirus (MERS-CoV) are considered as major community health events in the prior two 
decades. The case fatality tolls were 10% and 37% for SARS-CoV and MERS-CoV8 
respectively.  In December 2019, a novel coronavirus emerged in Wuhan City, Hubei Province 
of China.8 This outbreak was unique in terms of high pathogenicity and mortality compared to 
the earlier epidemics by coronaviruses.14 On 31st December 2019, WHO was apprised of cases 
of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was detected as 
the cause by Chinese authorities on 7th January 2020. Sooner cases affected by novel 
coronavirus were found outside Wuhan and eventually throughout the world. On January 30, 
2020, the World Health Organization announced the epidemic a public health emergency of 
international concern.6Later, WHO named the disease by novel coronavirus as “COVID-19”, 
which is a short form of “Coronavirus Disease 2019” on February 11, 2020. With a growing 
number of new cases and increased mortality attributable to COVID-19 pandemic11, global 
health discourses among the scientific community, policymakers, and the general population 
are emphasizing on what is known about this virus. Although it is known that COVID-19 
remains uniquely different than SARS-CoV and MERS-CoV, the scientific knowledge on 
COVID-19 remains limited within the scope of recently published articles. It is essential to 
understand the growth of emerging scientific data on COVID-19 to inform further investigation 




The public health emergency like the COVID-19 pandemic may affect different frontiers 
of human lives globally. To solve such problems, it is necessary to fully understand the problem 
and solutions that may address the same. This need for knowledge is a fundamental force that 
keeps science alive and allows scientists to thrive in their research domains bringing the best 
possible methods and materials to answer real-life questions. Solving a complex public health 
problem like COVID-19 needs robust knowledge generated through rigorous methods specific 
to each problem related to different dimensions of COVID-19 as well as the lives of millions 
of people around the world.  
 
2. Review of Literature 
LOU, J and others (2020) analysed the publications about “COVID-19 to summarize the 
research hotspots and make a review, to provide a reference for researchers in the world. They 
searched in PubMed using the keywords “COVID-19” from inception to March 1, 2020. 
Retrieved data included title, corresponding author, language, publication time, publication 
type, research focus. The analysis found that 183 publications published from 2020 January 14 
to 2020 February 29 were included in the study. The first corresponding authors of the 
publications were from 20 different countries. Among them, 78 (42.6%) from the hospital, 64 
(35%) from the university and 39 (21.3%) from the research institution. All the publications 
were published in 80 different journals. Journal of Medical Virology published most of them 
(n=25). 60 (32.8%) were original research, 29 (15.8%) were review, 20 (10.9%) were short 
communications. 68 (37.2%) epidemiology, 49 (26.8%) virology and 26 (14.2%) clinical 
features. According to them, China has provided a large number of research data for various 
research fields, during the outbreak of COVID-19. Most of the findings play an important role 
in preventing and controlling the epidemic around the world”.2 
Singh, Nirmal and others (2019) studied “Scientometric study and network visualization of 
journal articles on Nipah virus for a better understanding of research trends on the subject. 
Metadata of journal articles were retrieved from Scopus database in 2018. After removing 
unwanted and inadequate records. 1007 documents were analysed the publishing tendencies on 
Nipah Virus. The outcome of the study disclosed the inconsistent growth of publications on 
the subject. There were only some prolific authors with less than 15 articles. The USA led the 
world in terms of the highest contribution to the number of articles. A great degree of the inter-
country and inter-continent partnership was found among the US, Australia, Malaysia, United 
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Kingdom and Bangladesh portraying that the developed world is working in alliance with the 
developing nations to challenge the crisis”.5 
Wen-Ta Chiu, Jing-Shan Huang, Yuh-Shan Ho (2004) identified that “Severe Acute 
Respiratory Syndrome (SARS) has to turn out to be the major of health issues since its outbreak 
early 2003. The paper aims to perform a bibliometric analysis of all SARS-related publications 
available in the Science Citation Index (SCI) in the primary stage. An efficient examination 
was conducted by using the SCI for publications ever since the SARS outbreak early 2003. 
Chosen papers comprised of severe acute respiratory syndrome or SARS as a part of its title, 
abstract, or keyword from the initial phase of SARS outbreak, from March to till July 8, 2003. 
They contained limitations such as authorship, patterns of international collaboration, journals, 
language, and reprint address for study purpose. Citation analysis was based on the impact 
factor as defined by Journal Citation Reports (JCR) issued in 2002 and on the actual citation 
impact (ACI). Further researchers discovered that Thirty-two percent of the total share was 
published as news features, 25% as editorial materials, 22% as articles, 13% as letters, and the 
remaining being biographic items, corrections, meeting abstracts, and reprints. The US 
dominated the production by 30% of the total share followed diligently by Hong Kong with 
24%. Sixty-three percent of publication was published by the majority of countries. The SARS 
publication pattern in the past few months suggests immediate citation, low collaboration rate, 
and English and mainstream country domination in production. We observed no associations 
of research indexes with the number of cases”.5 
 
3. Objectives:  
3.1 To analyse retrospectively the available publications on Coronavirus Disease - 19  
3.2 To know the productive authors in the area of research 
3.3 To classify subject-wise and document wise publications in this field 
3.4 To suggest which organisations are at the forefront of the research 
3.5 To provide references for researchers in the world.  
 
4. Scope and Methodology 
We have undertaken this study to know who is studying on coronavirus, from which place, 
what is their affiliation, in which journal they published their articles, we have logged in to 
Scopus database to find out how many articles are published and how many citations are 
received by these publications. The above-mentioned researchers searched the Scopus database 
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using the following keyword “Coronavirus Disease 2019”, and accessed twenty years data from 
2001 to 2020. After retrieving the data, only suitable data on Coronavirus Diseases 2019 were 
extracted in Microsoft Excel format. Data were extracted directly from the database, regarding 
publications, title, corresponding author, author affiliation, author nationality, language, 
publication type etc. Studies revealed that very few bibliometric analysis has taken place on 
coronavirus literature. 
 
5. Analysis and Interpretation of Data 
Table No. 1 
Year wise Distribution of Publications and Citations 
Year No. of Publications No. of Citations Citations per Publication 
2020 55 (10.16)  28 (0.24) 0.50 
2019 38 (7.02) 41 (0.36) 1.07 
2018 34 (6.28) 145 (1.28) 4.26 
2017 36 (6.65) 209 (1.85) 5.80 
2016 36 (6.65) 256 (2.27) 7.11 
2013 33 (6.09) 371 (3.29) 11.24 
2015 29 (5.36) 381 (3.38) 13.13 
2014 25 (4.62)  337 (2.99) 13.48 
2003 25 (4.62) 395 (3.51) 15.8 
2011 25 (4.62) 556 (4.94) 22.24 
2010 24 (4.43) 593 (5.27) 24.70 
2004 21 (3.88) 551 (4.89) 26.23 
2012 22 (4.06)  611 (5.43) 27.77 
2001 13 (2.40) 368 (3.27) 28.30 
2008 14 (2.58) 418 (3.71) 29.85 
2005 32 (5.91) 1140 (10.13) 35.62 
2007 23 (4.25) 943 (8.38) 41 
2009 24 (4.43)  1023 (9.09) 42.62 
2002 12 (2.21) 815 (7.24) 67.91 





Figure No.1  
 
Table and Figure 1 analyses the publications published and citations received on the 
topic of Coronavirus Diseases - 19 published in different journals indexed in the Scopus 
database for a time frame of 20 years starting from 2001 to 2020. This duration resulted in the 
publication of 541 publications. This analysis showed that the most number of publications 
were published in the year 2020 with 55 (10.16%) publications and followed by 2019 with 38 
(7.02%), 2016 and 2017 with 36 (6.65%) publications each being published and ranked 1st, 2nd 
and 3rd place during the study.  
The growth of publications on Coronavirus during the period under the study was found 
to be uneven but slightly in increasing mode.  In the first 10 years (2001-2010) publications on 
Coronavirus is very less 38% (208) only, whereas later half from the year 2011-2020 
publications are raised to 62% (333). Publications are increased in the later year 2019 and 2020 
due to the spread of the Coronavirus all over the world.  
Topmost citations are found in the year 2006 with 2070 citations followed by 1140 and 
1023 in the year 2005 and 2009 respectively. Least citations are received in the year 2020 with 
28. On an average 562 citations are received in this twenty years of study. More than average 
citations are received in the year 2002, 2005, 2006, 2007, 2009, 2010 and 2012. It is understood 
from the study that, articles required more number of years to cite in different publications. But 




















No. of Publications No. of Citations
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now in the year 2020, a lot of articles will get citations, since this coronavirus is spread all over 
the world. 
Lowest citations per publications are in the year 2020 with 0.50, whereas the highest is 
in the year 2006 with 103.5. On an average 20.79 citations are received per publications 
throughout the reported period of twenty years.  
 
Table No. 2 
Relative Growth Rate and Doubling Time 









2001 13 13 - 2.564 - 1.636 - 2.360 
2002 12 25 2.564 3.218 0.654 0.943 
2003 25  50 2.484 3.912 1.428 2.060 
2004 21 71 3.218 4.262 1.044 1.506 
2005 32 103 3.044 4.634 1.59 2.294 
2006 20 123 3.465 4.812 1.347 1.943 
2007 23 146 2.995 4.983 1.988 2.868 
2008 14 160 3.135 5.075 1.94 2.799 
2009 24 184 2.639 5.214 2.575 3.715 
2010 24 208 3.178 5.337 2.159 3.115 














2012 22 255 3.218 5.541 2.323 3.352 
2013 33 288 3.091 5.662 2.571 3.709 
2014 25 313 3.496 5.746 2.25 3.246 
2015 29 342 3.218 5.834 2.616 3.774 
2016 36 378 3.367 5.934 2.567 3.704 
2017 36 414 3.583 6.025 2.442 3.523 
2018 34 448 3.583 6.104 2.521 3.637 
2019 38 486 3.526 6.186 2.66 3.838 




Figure No. 2 
 
 
Relative Growth Rate (RGR) means the growth in a number of publications per unit of 
time which is shown in Table and Figure 2, out of the following calculation. The mean relative 
growth rate R (1-2) over a specific period of the interval can be calculated from the following 
equation6. 
 
R (1-2) =W2-W1/T2-T1 
 
Where, R = Mean relative progress rate over the specific period of interval; 
 
W1 = Natural record of preliminary number of publications 
 
W2 = Natural record of last number of publications. 
 
T2 – T1 = Unit variance between the initial time and final time. 
 
Further table 2 indicates the RGR and DT of Coronavirus – 2019 publications output. 
The mean RGR has been increased from 1.636 in the first half to 2.487 in the second half, 
y = 0.093x - 184.98
R² = 0.762
















































whereas the mean doubling time is increased from 2.360 to 3.589 during the same period. The 
mean relative growth for the first five years (2001 to 2010) showed a growth rate of 1.636 
whereas the mean relative growth for the last five year (2011 to 2020) increased to 2.487. The 
corresponding doubling time for different years gradually increased from 0.943 in 2002 to 
3.832 in 2020. Doubling Time is reached to its peak in the year 2019 and lowest DT can be 
found in the year 2002.  Thus the rate of growth of publication was increased correspondingly 
doubling time also increased. It is observed from the table and figure, there is a very less gap 
between the relative growth rate and doubling time in the initial years, as it is progressed year 
after year we can see a wide gap between the relative growth of publications and doubling time 
also.  
  
Table No. 3 
Author wise Distribution of Publications 
Name of the Author’s No. of 
Publications 
Rank 
Akashi, M. 11 (2.82) 1 
Hamada, K., Kaneko, T. (2x6=12) 12 (3.07) 2 
Akagi, T., Chen, M.Q., De Groot, R.J., Drosten, C., 
Rottier, P.J.M. (5x5=25) 
25 (6.41) 3 
Alenius, S., Baba, M., Giuliano, A.R., Grünweller, A., 
Ziebuhr, J., (5x4=20) 
20 (5.12) 4 
Abrahamsen, M.,Basak, A.,Basak, S.,Biswas, P., De Clercq, E., 
Dunne, E.F., Emanuelson, U., Fischer, W.B., Flores, R., Goyal, 
S.M., Haagmans, B.L., Harris, R.B., Hildt, E., Huizinga, E.G., 
Koopmans, M., Langereis, M.A., Memish, Z.A., Morikawa, S., 
Müller, M.A., Nielson, C.M., Smits, S.L., Snijder, E.J., Spaan, 
W.J.M., Steinmetz, N.F., Yamamoto, N., Zeng, Q. (26x3=78) 
78 (20) 5 
Abdul-Careem, M.F., Aboul-Ela, F.,  Addie, D.D., Al-Tawfiq, 
J.A., Amiroch, S., Arabi, Y.M., Assiri, A., Baker, S.C., 
BaldelliBombelli, F., Balkhy, H., Balzarini, J., Bankiewicz, K.S., 
Barnard, D.L., Bayry, J., Berardi, A., Berry, S., Bhunia, A., 
Binger, T., Bossi, P., Bricaire, F., Bringas, J., Catroxo, M.H.B., 
Chen, H.W., Chen, P.J., Chen, Y.I., Choi, B.R., Choi, J.Y., 
240 (61.53) 6 
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Chrétien, M., Chuang, C.P.J., Chuang, C.Y., Cobigo, Y., 
Coenjaerts, F.E.J., Collisson, E.W., Cork, S.C., Corman, V.M., 
Crouch, C.F.,Crusio, K.M., Daszak, P., Decaro, N., Deka, D., 
Dhume, K., Drexler, J.F., Elgner, F., Fang, W., Fang, Z.S., 
Farag, E., Finn, C., Forsayeth, J., Francis, M.J., Ganguly, S., 
Geldenhuys, M., Ghosh, A., Glitscher, M., Gorbalenya, A.E., 
Granzow, H., Hadaczek, P., Hanes, J.,  Hartmann, R.K., 
Hashimoto, S., Hashimoto, Y., Hellmuth, J., Herrler, G., Hogan, 
C.J., Horzinek, M.C., Hsu, H.J., Hu, C.M.J., Huang, W., 
Huang, Y.C., Huo, Q., Ieki, R., Im, S.G., Isa Irawan, M., Ishida, 
I., Jang, B., Jeong, H.S., Jha, S., Kanamaru, N., Kase, T., 
Kettleson, E.M., Kim, J., Kim, J.S., Kirikae, T., Kita, Y., 
Kramer, A., Kurita, H., Lange-Grünweller, K., Lee, H., Lee, 
H.K., Lee, J., Lee, K., Lee, M.H., Lee, S., Li, L., Lin, Y.C., 
Lipkin, W.I., Lomonossoff, G.P., Luo, C.H., Maddineni, S., 
Maiti, B.C., Maity, T.K., Markotter, W., Markowitz, L.E., 
Martins, A.M.C.R.P.F., Masters, P.S., Mastorakos, P., 
McKinstry, K.K., Misra, V., Mizuno, A., Mortlock, M., Müller, 
C., Nagalakshmi, G., Nomura, T., Nour, M., Obermann, W.,  
Ohlson, A., Okada, M.,Okuno, Y., Osterhaus, A.D.M.E., 
Papenfuss, M.R., Paul, R. (120x2=240) 
Unidentified 4 (1.02) 7 
 
Table 3 displays the ranking of authors of research articles. It is observed that there is 
a total of 390 publications are written by 163 authors’ on Coronavirus topic during the study 
period. Further, it shows that most prolific authors during the year 2001-2020. Akashi, M. 
published 11 (2.82%) articles with 148 Total Global Citation Score, 2nd position is shared by 
two authors i.e.: Hamada, K. and Kaneko, T. and published 6 (1.56%) articles each and Akagi, 
T., Chen, M.Q., De Groot, R.J., Drosten, C., Rottier, P.J.M. five authors individually published 
5 (6.41%) articles each on Coronavirus. Top eight authors (1st, 2nd and 3rd Rank holders) 
contributed 12.3% (48) publications.  More than 1/3 of the articles are written by the multi 
authors by collaborating on this topic. Very thin publications are visible from single-author 
publications (2.82%), remaining 97.18% of publications are written by joint authors. 
12 
 
Table No. 4 
Subject wise Distribution of Publications 
Subject Area No. of Publications Rank 
Medicine 227 (26.42) 1 
Immunology and Microbiology 111 (12.92) 2 
Biochemistry, Genetics and Molecular Biology 108 (12.57)  3 
Veterinary 77 (8.96) 4 
Pharmacology, Toxicology and Pharmaceutics 56 (6.51)  5 
Agricultural and Biological Sciences 53 (6.16) 6 
Chemistry 40 (4.65) 7 
Engineering 34 (3.95) 8 
Materials Science 28 (3.25) 9 
Environmental Science 22 (2.56) 10 
Table 4 represents the most productive research area-wise distribution of the 
publications. Out of the top 10 most productive research areas, maximum number 227 
(26.42%) publications are available in the Medicine discipline. This is followed by 
Immunology and Microbiology discipline with 111 (12.92%) articles and Biochemistry, 
Genetics and Molecular Biology discipline with 108 (12.57%) articles. 541 publications on 
Coronavirus is scattered in 25 subject disciplines in these publications. Further, it is known that 
more than 50% of the publications have belonged Medicine field. 
Table No. 5 
Document wise Distribution of Publications 
Document Type No. of Publications 
Article 405 (74.86) 
Review 65 (12.01) 
Conference Paper 24 (4.43) 
Book Chapter 14 (2.58)  
Letter 14 (2.58) 
Editorial 7 (1.29) 
Note 5 (0.92) 
Short Survey 5 (0.92)  
Book 2 (0.36) 
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Distribution of publications in a different type of documents is depicted in Table 5. The 
topic on “Coronavirus” publications was spread over a range of publication types like Journal 
Articles with 405 publications (74.86%) followed by Reviews with 65 (12.01%)  and 
Conference Papers 24 (4.43%). First three type of publications together produced more than 
91% of the publications. Only Article and Review type of publications are more than average 
publications. Remaining forms of documents are very less. 
Book chapters and Letter’s together shared 4th place in publications with 14 (2.58%) 
publications each. Editorial with 7 (1.29%) publications, 5 (0.92%) publications each are 
published in the form of Notes and Short Surveys. Very less number of publications are 
published in book 2 (0.36%) form. 
Table No. 6 
Source wise Distribution of Publications 
Rank Source Title No. of Publications Zone 
1.  PLOS One 12 (3.89) Zone 1=21 
Journals 2.  Antiviral Research 9 (2.92) 
3.  Journal Of Virology 7 (2.27) 
4.  Virology 6 (1.94) 
5.  Polymer Preprints Japan 5 (1.62) 
6.  Zhejiang Da XueXueBao Yi Xue 
Ban Journal Of Zhejiang University 
Medical Sciences 
5 (1.62) 
7.  13 journals  having 4 articles each  52 (16.77) 
8.  2 journals having 3 articles each  6 (1.94) 
9.  13 journals having 3 articles each 
Advanced Healthcare Materials 
39 (12.61) Zone 2 = 44 
Journals 
10.  31 Journals having 2 articles each  62 (19.84) 
11.  9 Journals having 2 articles each  18 (5.76) Zone 3 = 94 
Journals 12.  85 Journals having 1 article each  85 (27.2) 
Table 6 reveals that PLOS One journal published highest 12 (3.89%) number of 
publications, Antiviral Research published 9 (2.92%) papers, Journal Of Virology published 7 
(2.27%) papers, Virology journal published 6 (1.94%), Polymer Preprints Japan and Zhejiang 
Da XueXueBao Yi Xue Ban Journal Of Zhejiang University Medical Sciences journal 
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published each 5 (1.62%) articles. Whereas, 13 journals published 4 articles each and 15 
journals published 3 papers each, 2 (0.64%) each publication are available in 41 journals, one 
article each is published in 85 number of journals in this period on Coronavirus. 308 
publications on Coronavirus had been published in 160 journals. The six core journals 
published 44 (14.26%) articles, of the total journal publications. 
Application of Bradford’s Law of Scattering 
Bradford’s Law of Scattering helps in providing overall advice to the librarians to find out the 
number of core journals in any given subject matter. In this study also, journals are divided into 
three equal parts having the same number of publications in each part.  
Zone 1: Core journals in the Medicine field, is relatively few in number but they have produced 
approximately 1/3 of all the articles.  
Zone 2: is having less quantity of articles but available in more number of journals compared 
to zone 1 (almost double in number).  
Zone 3: in this zone an equal number of publications as in first and second zone, but still a 
higher amount of journals compared to zone 2 journals.  
 
Table No. 7 
Affiliation wise Distribution of Publications 




1.  Utrecht University, Netherlands 28 (19.71) 1 
2.  Osaka University, Japan 12 (8.45) 2 
3.  
Rega Institute for Medical Research, Central 
Belgium 
11 (7.74) 3 
4.  National Institutes of Health, Bethesda, Maryland 9 (6.33) 
4 
 
5.  Japan Science and Technology Agency, Japan 9 (6.33) 
6.  Katholieke Universiteit Leuven, Flanders, Belgium 9 (6.33) 
7.  Erasmus Medical Centre, Rotterdam, Netherlands 9 (6.33) 
8.  Chinese Academy of Sciences, Beijing, China 7 (4.92) 5 
9 University of California, Davis, United States 6 (4.22) 6 
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Justus Liebig University Giessen, Gieben, Germany 6 (4.22) 
Centers for Disease Control and Prevention 6 (4.22) 
University of California, San Francisco, United 
States 
6 (4.22) 
Charité – UniversitätsmedizinBerlin, Germany 6 (4.22) 
Zhejiang University School of Medicine, China 6 (4.22) 
National Institute of Infectious Diseases 6 (4.22) 
King Saud bin Abdul Aziz University for Health 
Sciences, Riyadh, Saudi Arabia 
6 (4.22) 
The productivity of the author publications based on their institutions is depicted in 
Table 7. Here institutions are ranked according to the number of publications published by the 
institutions. It is found that a total of 160 institutions, including 3436 subdivisions published 
549 research papers during 2001 – 2020. The top eight most prolific Universities / R&D 
organisations/institutions involved in this research have published 94 out of 541 research 
articles. Among the institutions, 1st place is got by Utrecht University with 19.71% 
publications, followed by Osaka University and Rega Institute for Medical Research with 
8.45% and 7.74% publications 
 
Table No. 8 
Country wise Distribution of Publications 
Rank Name of the Country No. of Publications 
1.  United States 145 (19.83) 
2.  China 61 (8.34) 
3.  Germany 51 (6.97) 
4.  India 44 (6.01) 
5.  Japan 43 (5.88) 
6.  Netherlands 29 (3.96) 
7.  Saudi Arabia 29 (3.96) 
8.  United Kingdom 27 ( 3.69) 
9.  South Korea 22 (3.00) 




Figure No. 3 
 
Country-wise ranking is provided in table 8 and figure 3. The 541 publications on the 
topic of Coronavirus published by different countries. The analysis of the country-wise 
distribution of the articles in which the researchers have published their works revealed that 
the highest percentage of the total publications on Coronavirus was published by the USA with 
19.83 followed by, China with 8.34% and Germany with 6.97%. India published 44 (6.01%) 
publications on this topic and ranked 4th nation. It shows that American researchers are very 
much interested in researching on the Coronavirus topic because this virus is affected a lot on 
human life and the economy of the USA. It has resulted in more number of research articles. 
And this study is also supported by the study made by Wen-Ta in his article on Bibliometric 
Analysis of Severe Acute Respiratory Syndrome related research in the beginning stage 
published in Scientometric journal in the year 20047. Out of 541 publications, 487 publications 
are from the top 10 countries. In all, 67 countries published on the Coronavirus topic. The 
remaining publications were scattered in the journals published from seventy-six countries in 
this world. Eleven publications are of unidentified countries. 69% of the publications are from 




Table No. 9 
Language wise Distribution of Publications 
Languages No. of Publications Rank 
English 469 (85.42) 1 
German 17 (3.13) 2 
Chinese 15 (2.76) 3 
Japanese 13 (2.39) 4 
Spanish 6 (1.10) 5 
Polish 4 (0.73 ) 6 
Hungarian 3 (0.55 ) 7 
Dutch, French, Russian, Turkish  
4x2 (0.36)=8 (1.44) 
2 (0.36) 8 
Bulgarian, Croatian, Danish, Greek, Hebrew, 
Italian, Korean and Slovenian 
8x1(0.18)=8 (1.44) 
1 (0.18) 9 
Table 9 reveals that research publications are published in the nineteen different 
languages of the world. The English language stood first by publishing 85.42% (469) of the 
publication during the study period on Coronavirus. Followed by German and Chinese 
languages with 3.13% (17) and 2.76% (15) publications on the respective languages and stood 
2nd and 3rd position in this study. Remaining sixteen languages published just 8.69% 
publications. Only English language published articles more than average publications. It is 
confirmed that once again English is the principal language of research communication in this 
world. 
 
Table No. 10 
Access wise Distribution of Publications 
Type of Access No. of Publications 
Open Access 243(45) 
Print Access 298(55) 
It is noticed from the table 10 that, among the publications, 55% of the publications are 
published in the Printed Journals / Books / Conference Proceedings and others, whereas only 
45% of the publications are published in the Open Access journals and other reading materials. 
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It is understood that gradually use of e-resources is increasing, in this study nearly 50% of the 
scholars are using e-resources. 
 
6. Findings: 
6.1 This analysis indicated that highest amount of publications were published throughout the 
year 2020 with 55 (10.16%) publications, followed by 2019 with 38 (7.02%) publications, 
and 2016 and 2017 with 36 (6.65%) publications being published and ranked 1st, 2nd and 
3rd place. 
6.2 In the first 10 years (2001-2010) publications on Coronavirus is very less 38% only, 
whereas. Later half from the year, 2011-2020 publications are raised to 62%.  
6.3 2.39% of the publications are written by 163 authors’ on Coronavirus topic during the study 
period. 
6.4 Single author publications are very less (2.82%) compared to multi-authored (97.18%) 
publications.  
6.5 Highest number of 227 (26.42%) articles are published in the Medicine discipline. This is 
followed by Immunology and Microbiology discipline with 111 (12.92%) articles and 
Biochemistry, Genetics and Molecular Biology discipline with 108 (12.57%) articles.   
6.6 The topic on “Coronavirus” publications were spread over a range of publication type like 
Journal Articles with 405 (74.86%) in number is the highest publications followed by 
Reviews with 65 (12.01%) and Conference Papers 24 (4.43%). Journal articles, reviews 
and conference papers produced more than 91% of the publications. 
6.7 PLOS One journal published highest 12 (3.89%) papers on COVID-19. 
6.8 Out of 160 institutions, top 10 institutions published 142 research papers and the rest of the 
institutions/organisations published 399 research papers respectively. Among the 
institutions, 1st place is got by Utrecht University with 19.71% publications, followed by 
Osaka University and Rega Institute for Medical Research with 8.45% and 7.74% 
publications 
6.9 The analysis of country-wise scattering of the publications in which the researchers have 
published their works revealed that the highest percentage of the total publications on 
Coronavirus was dominated by the USA with 19.83 followed by, China with 8.34% and 
Germany with 6.97%. India published 44 (6.01%) publications on this topic. 
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6.10 Research publications are published in the nineteen languages of the world. But English 
language stood first by publishing 85.42% (469) of the publication during the study period 
on Coronavirus. 
6.11 Among the publications 55% of the publications are published in the Printed Journals / 
Books / Conference Proceedings and others, whereas only 45% of the publications are 
published in the Open Access journals and other reading materials. 
 
7. Conclusion: 
Coronavirus is not only a recently emerged fast-spreading disease, at the same time it 
is a new topic for research scholars also. Although the major Coronavirus Disease 2019 
bursts in China, the great percentage of participation from developed nations of the world, 
imply that COVID – 19 rampant is not just a national concern of any one country but a 
virus that spread everywhere one must be conscious about it. 
These research findings play an important role in knowing which author is working on 
which topic, where he is working, whom to contact the latest information on this epidemic. 
Average citations per publication on this topic is 20.79. Now almost all the papers are 
written by multi-authors, it shows that it is an era of joint authors. Still, research is going 
on Coronavirus, maybe by the end of this year we may get an effective vaccine for this 
virus. This study provided a global bibliometric evaluation of COVID-19 studies, which 
may facilitate ongoing and future research.  
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